allyl cyclopentyl ether | 60138-46-7

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: allyl cyclopentyl ether
• 英文别名: (allyloxy)cyclopentane；Prop-2-enoxycyclopentane
• CAS: 60138-46-7
• 化学式: C₈H₁₄O
• 分子量: 126.199
• InChiKey: TVBYBOXTCMHVFP-UHFFFAOYSA-N

物化性质

• 沸点：
  159.3±9.0 °C(Predicted)
• 密度：
  0.87±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2
• 重原子数：
  9
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.75
• 拓扑面积：
  9.2
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  allyl cyclopentyl ether 在 lithium diisopropyl amide 作用下， 以 四氢呋喃 、 正戊烷 为溶剂， 以83%的产率得到(Z)-(prop-1-en-1-yloxy)cyclopentane
  参考文献：
  名称：

  Isomerization of Allyl Ethers Initiated by Lithium Diisopropylamide

  摘要：

  Lithium diisopropylamide (LDA) promotes virtually quantitative conversion of allylic ethers to (Z)-propenyl ethers. It was discovered that allylic ethers can be isomerized efficiently with very high stereoselectivity to (Z)-propenyl ethers by LDA in THF at room temperature. The reaction time for the conversion increases with more sterically hindered allylic ethers. Different amides were also compared with LDA for their ability to effect this isomerization.

  DOI：

  10.1021/ol102029u
• 作为产物：
  描述：

  allyl cyclopentyl carbonate 在 tris(dibenzylideneacetone)dipalladium(0) chloroform complex 、 三苯基膦 作用下， 以 四氢呋喃 为溶剂， 反应 5.0h， 生成 allyl cyclopentyl ether
  参考文献：
  名称：

  钯，铑，钌，钼和镍络合物催化的烯丙基碳酸酯的反应；亲碳亲核剂的烯丙基化和脱羧-脱氢

  摘要：

  已经研究了各种过渡金属络合物催化的碳亲核试剂与烯丙基碳酸酯的烯丙基化。发现钯，铑，钌，镍和钼络合物是活性催化剂。铑催化剂显示出与其他催化剂不同的区域选择性，该反应可以在没有烯丙基重排的情况下进行。在不存在亲核试剂的情况下，碳酸烯丙基烷基酯通过脱羧-脱氢转化为酮。钌催化剂在该反应中活性最高。

  DOI：

  10.1016/0022-328x(85)80354-5

文献信息

• Dehydrogenation of alcohols with allyl carbonates catalyzed by palladium or ruthenium complexes
  作者：Ichiro Minami、Jiro Tsuji

  DOI：10.1016/s0040-4020(01)81672-0

  日期：——

  alkyl allyl carbonates with a phosphine-free palladium catalyst in acetonltrile affords ketones or aldehydes in high yields. This new method of oxidation of alcohols via allyl carbonates can be applied to various alcohols except simple primary alcohols. The reaction proceeds under neutral conditions and hence various acid- or base-sensitive functional groups are not affected during the reaction. Ruthenium

  用无膦的钯催化剂在乙腈中处理碳酸烷基烯丙酯可高产率得到酮或醛。这种经由碳酸烯丙酯氧化醇的新方法可应用于除简单伯醇之外的各种醇。反应在中性条件下进行，因此在反应过程中不影响各种对酸或碱敏感的官能团。氢化钌配合物也是一种有效的催化剂。仲或烯丙基醇的直接脱氢反应是通过钌络合物的催化作用与碳酸烯丙酯反应进行的。1,4-二醇和1,5-二醇与过量的碳酸烯丙酯转化为内酯。
• 2,3,4,9-Tetrahydro-1H-carbazoles
  申请人：Bayer Schering Pharma Aktiengesellschaft

  公开号：EP1975159A1

  公开（公告）日：2008-10-01

  The present invention relates to 2,3,4,9-tetrahydro-1 H-carbazoles of the general formula I, in which Q, X, W, R1, R2, R3, R4 and R5 have the meaning as defined in the description. The compounds according to the invention are effective FSH antagonists and can be used for example for fertility control in men or in women, or for the prevention and/or treatment of osteoporosis.

  本发明涉及通式I的2,3,4,9-四氢-1H-咔唑， 其中Q、X、W、R1、R2、R3、R4和R5的含义如描述中所定义。 根据本发明的化合物是有效的FSH拮抗剂，可用于男性或女性的生育控制，或用于骨质疏松症的预防和/或治疗。
• Arylmethylene substituted N-acyl-beta-amino alcohols
  申请人：Bayer Schering Pharma Aktiengesellschaft

  公开号：EP2018859A1

  公开（公告）日：2009-01-28

  The present invention relates to arylmethylene substituted N-Acyl-β-amino alcohols of the formula I in which Y is selected from the aryl or heteroaryl groups: and R1, R2, R3, R4, R5, Q, X and W have the meaning as defined in the description. The compounds according to the invention are effective FSH antagonists and can be used for example for fertility control in men or in women, or for the prevention and/or treatment of osteoporosis.

  本发明涉及式I的芳基亚甲基取代的N-酰基-β-氨基醇 其中 Y 从芳基或杂芳基中选择: 和 R1、R2、R3、R4、R5、Q、X和W的含义如描述中所定义。 根据本发明的化合物是有效的FSH拮抗剂，例如可用于男性或女性的生育控制，或用于骨质疏松症的预防和/或治疗。
• Cyanomethyl substituted N-Acyl Tryptamines
  申请人：Bayer Schering Pharma Aktiengesellschaft

  公开号：EP2020404A1

  公开（公告）日：2009-02-04

  The present invention relates to cyanomethyl substituted N-acyl tryptamines of the formula I in which R1, R2, R3, R4, R5, Q, X and W have the meaning as defined in the description. The compounds according to the invention are effective FSH antagonists and can be used for example for fertility control in men or in women, or for the prevention and/or treatment of osteoporosis.

  本发明涉及具有以下结构的氰甲基取代的N-酰基色胺化合物，其中R1、R2、R3、R4、R5、Q、X和W的含义如描述中所定义。根据本发明的化合物是有效的FSH拮抗剂，可用于男性或女性的生育控制，或用于骨质疏松症的预防和/或治疗。
• Sulphonyltryptophanols
  申请人：Bayer Schering Pharma Aktiengesellschaft

  公开号：EP1964834A1

  公开（公告）日：2008-09-03

  The present invention relates to sulfonyltryptophanols of the general formula I, in which Q, X, W, R1, R2, R3, R4, R5, R6, R7 and R8 have the meaning as defined in the description. The compounds according to the invention are effective FSH receptor antagonists and can be used for example for fertility control in men or in women, or for the prevention and/or treatment of osteoporosis.

  本发明涉及通式I的磺酰色氨酸醇类化合物，其中Q、X、W、R1、R2、R3、R4、R5、R6、R7和R8的含义如描述中所定义。根据本发明的化合物是有效的FSH受体拮抗剂，可用于男性或女性的生育控制，以及骨质疏松症的预防和/或治疗。